Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 15701716)

Published in Blood on February 08, 2005

Authors

Regis Doyonnas1, Julie S Nielsen, Shierley Chelliah, Erin Drew, Takahiko Hara, Atsushi Miyajima, Kelly M McNagny

Author Affiliations

1: The Biomedical Research Centre, University of British Columbia, 2222 Health Sciences Mall, Vancouver, Canada V6T 1Z3.

Articles citing this

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. Br J Cancer (2011) 1.64

Endomucin, a CD34-like sialomucin, marks hematopoietic stem cells throughout development. J Exp Med (2005) 1.44

Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol (2010) 1.40

The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS One (2007) 1.25

Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J Proteome Res (2010) 1.23

CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J (2011) 1.21

Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. Exp Hematol (2008) 1.10

SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood (2006) 1.08

Erythropoietin receptor response circuits. Curr Opin Hematol (2010) 1.07

Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. Blood (2007) 1.06

Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation. Mol Cell Biol (2009) 1.05

CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools. Blood (2009) 1.01

Podocalyxin is a marker of poor prognosis in colorectal cancer. BMC Cancer (2014) 0.99

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma. BMC Clin Pathol (2015) 0.94

Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy. Breast Cancer Res (2015) 0.92

Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. PLoS One (2013) 0.91

A familiar stranger: CD34 expression and putative functions in SVF cells of adipose tissue. World J Stem Cells (2013) 0.88

A comparative study of two PODXL antibodies in 840 colorectal cancer patients. BMC Cancer (2014) 0.88

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma. PLoS One (2015) 0.88

Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion. PLoS One (2014) 0.87

Pleomorphic extra-renal manifestation of the glomerular podocyte marker podocalyxin in tissues of normal beagle dogs. Histochem Cell Biol (2006) 0.85

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system. Stem Cell Res Ther (2015) 0.84

Podocalyxin as a Prognostic Marker in Gastric Cancer. PLoS One (2015) 0.84

Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res (2009) 0.83

Expression of podocalyxin separates the hematopoietic and vascular potentials of mouse embryonic stem cell-derived mesoderm. Stem Cells (2014) 0.83

A compendium of urinary biomarkers indicative of glomerular podocytopathy. Patholog Res Int (2013) 0.81

Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front Oncol (2014) 0.81

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer. J Transl Med (2016) 0.79

Immunohistochemical localisation of TRA-1-60, TRA-1-81, GCTM-2 and podocalyxin in the developing baboon kidney. Histochem Cell Biol (2008) 0.78

Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes. PLoS One (2011) 0.77

Novel Roles for Podocalyxin in Regulating Stress Myelopoiesis, Rap1a and Neutrophil Migration. Exp Hematol (2017) 0.75

Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells. Glycoconj J (2017) 0.75

Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis. Oncotarget (2016) 0.75

Articles by these authors

Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci (2011) 4.21

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem (2003) 3.30

The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell (2009) 3.08

Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep (2012) 2.83

Hematopoietic stem cells do not engraft with absolute efficiencies. Blood (2005) 2.81

Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci (2003) 2.38

Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity (2012) 2.34

Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development (2009) 2.26

Novel functions of the CD34 family. J Cell Sci (2008) 2.18

The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells. Nat Genet (2007) 2.10

Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02

Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res (2004) 1.90

Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice. Nat Immunol (2006) 1.89

Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol (2012) 1.79

Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci (2004) 1.78

Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem (2007) 1.75

Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta (2009) 1.75

Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J Biochem (2010) 1.73

Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J Exp Med (2005) 1.72

The role of podocalyxin in health and disease. J Am Soc Nephrol (2009) 1.66

Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis. Proc Natl Acad Sci U S A (2012) 1.61

ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma. PLoS Biol (2011) 1.53

Liver progenitor cells develop cholangiocyte-type epithelial polarity in three-dimensional culture. Mol Biol Cell (2007) 1.44

Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood (2003) 1.43

Retracted A cell cycle-dependent co-repressor mediates photoreceptor cell-specific nuclear receptor function. EMBO J (2007) 1.39

TRB2, a mouse Tribbles ortholog, suppresses adipocyte differentiation by inhibiting AKT and C/EBPbeta. J Biol Chem (2007) 1.35

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers (2009) 1.35

Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos. Blood (2003) 1.34

Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: drastic change of EpCAM expression during liver development. Mech Dev (2009) 1.32

Cytokine regulation of liver development. Biochim Biophys Acta (2002) 1.29

Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J Biochem (2011) 1.29

Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes. FASEB J (2007) 1.29

Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology (2004) 1.25

The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS One (2007) 1.25

CD34 facilitates the development of allergic asthma. Blood (2007) 1.25

CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity (2005) 1.22

miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology (2013) 1.22

The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat Commun (2011) 1.19

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res (2013) 1.18

Liver regeneration by stem/progenitor cells. Hepatology (2014) 1.17

Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice. J Biochem (2003) 1.17

CD34 is a specific marker of mature murine mast cells. Exp Hematol (2002) 1.16

Grainyhead-like 2 regulates epithelial morphogenesis by establishing functional tight junctions through the organization of a molecular network among claudin3, claudin4, and Rab25. Mol Biol Cell (2012) 1.15

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS One (2008) 1.14

p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver. Gastroenterology (2008) 1.14

Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts. J Cell Sci (2004) 1.14

Essential function of oncostatin m in nociceptive neurons of dorsal root ganglia. J Neurosci (2004) 1.14

The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma. Clin Exp Metastasis (2012) 1.13

Crucial role of the small GTPase ARF6 in hepatic cord formation during liver development. Mol Cell Biol (2006) 1.12

CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation (2009) 1.11

Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J Biol Chem (2012) 1.07

Characterization and functional analyses of hepatic mesothelial cells in mouse liver development. Gastroenterology (2010) 1.07

CXCL14 deficiency in mice attenuates obesity and inhibits feeding behavior in a novel environment. PLoS One (2010) 1.06

Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol (2005) 1.06

FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev (2013) 1.05

Generation of transgenic rats expressing green fluorescent protein in S-100beta-producing pituitary folliculo-stellate cells and brain astrocytes. Endocrinology (2007) 1.05

K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J (2002) 1.05

Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes (2013) 1.05

Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development (2012) 1.04

Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability. J Immunol (2009) 1.03

SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog (2013) 1.02

Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol (2009) 1.01

Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation. PLoS One (2010) 1.01

Liver progenitor cells fold up a cell monolayer into a double-layered structure during tubular morphogenesis. Mol Biol Cell (2009) 1.00

Hedgehog signal activation coordinates proliferation and differentiation of fetal liver progenitor cells. Exp Cell Res (2009) 1.00

Development of murine hepatic sinusoidal endothelial cells characterized by the expression of hyaluronan receptors. Dev Dyn (2007) 0.99

Macrophage colony stimulating factor modulates the development of hematopoiesis by stimulating the differentiation of endothelial cells in the AGM region. Blood (2002) 0.99

Molecular mechanism of liver development and regeneration. Int Rev Cytol (2007) 0.98

Mitochondria and apicoplast of Plasmodium falciparum: behaviour on subcellular fractionation and the implication. Mitochondrion (2006) 0.98

SHIP1 is a repressor of mast cell hyperplasia, cytokine production, and allergic inflammation in vivo. J Immunol (2009) 0.97

Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J Biol Chem (2006) 0.97

The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma. Am J Respir Crit Care Med (2010) 0.96

Nucleocytoplasmic shuttling of the zinc finger protein EZI Is mediated by importin-7-dependent nuclear import and CRM1-independent export mechanisms. J Biol Chem (2007) 0.96

Transcription elongation factor S-II is required for definitive hematopoiesis. Mol Cell Biol (2006) 0.95

CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis. Am J Pathol (2010) 0.95

Prospero-related homeobox 1 and liver receptor homolog 1 coordinately regulate long-term proliferation of murine fetal hepatoblasts. Hepatology (2008) 0.95

STAT3 down-regulates the expression of cyclin D during liver development. J Biol Chem (2002) 0.95

Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer. Pharmacogenomics (2010) 0.95

Interleukin-11 reduces TLR4-induced colitis in TLR2-deficient mice and restores intestinal STAT3 signaling. Gastroenterology (2010) 0.94

A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis. Exp Hematol (2010) 0.94

Inducible expression of Wnt genes during adult hepatic stem/progenitor cell response. FEBS Lett (2009) 0.94

Expression of Dlk/Pref-1 defines a subpopulation in the oval cell compartment of rat liver. Gene Expr Patterns (2004) 0.93

α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals. J Biol Chem (2012) 0.93

Circulating IGF-binding protein 7 (IGFBP7) levels are elevated in patients with endometriosis or undergoing diabetic hemodialysis. Reprod Biol Endocrinol (2008) 0.93

A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk). Development (2010) 0.93

Spermatogonia-dependent expression of testicular genes in mice. Dev Biol (2002) 0.93

Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development. EMBO J (2007) 0.93

Spermatogonial cell-mediated activation of an IkappaBzeta-independent nuclear factor-kappaB pathway in Sertoli cells induces transcription of the lipocalin-2 gene. Mol Endocrinol (2005) 0.93

CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration. Stem Cells (2011) 0.92

Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells. Blood (2007) 0.92

Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene (2005) 0.92

CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis. FEBS Lett (2013) 0.92